PremiumRatingsActinium Pharmaceuticals: Promising Clinical Advancements and Strong Financial Outlook Support Buy Rating Actinium Pharma enters research collaboration with Memorial Sloan Kettering Promising Phase 1b Trial Results for Actinium Pharmaceuticals’ Actimab-A in r/r AML Support Buy Rating PremiumRatingsActinium Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Developments and Strategic Partnerships Is ATNM a Buy, Before Earnings? Actinium Pharmaceuticals initiates Actimab-A Triplet combination frontline trial PremiumThe FlyActinium Pharmaceuticals: Phase 3 SIERRA results of Iomab-B published in JCO Biotech Alert: Searches spiking for these stocks today B. Riley downgrades Actinium on ‘negative surprise’ from FDA 
